Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A four-drug combination cured all individuals who had experienced prior treatment failure.
Viral hepatitis is linked to adverse outcomes in pregnant people, underscoring the need for hepatitis B and C screening.
Latino individuals are at higher risk for NAFLD, but Black people with NAFLD are more likely to develop cirrhosis.
Intensive lifestyle management led to weight loss and reduced steatosis and fibrosis.
Pairing HCV testing and treatment eliminates the need to navigate the medical system.
Abdominal obesity worsened the impact of air pollution on MAFLD development.
Over the next two decades, obesity-linked NASH will lead to more deaths and high cost in the United States.
Even with this increase, older individuals now have better transplant outcomes.
HCV treatment initiation dropped by 31% from March to April 2020 and remained low throughout the year.
The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.